Exception Cementless Hip Stem

Active, not recruitingOBSERVATIONAL
Enrollment

332

Participants

Timeline

Start Date

January 1, 2021

Primary Completion Date

May 1, 2024

Study Completion Date

December 31, 2025

Conditions
Osteoarthritis, HipRheumatoid ArthritisInflammatory ArthritisCongenital Hip DysplasiaAvascular Necrosis of HipFemoral Neck Fractures
Interventions
DEVICE

Total hip arthoplasty (THA)

Total hip arthroplasty (THA) is a common operative treatment where an arthritic, degenerative or fractured hip joint is replaced with a prosthetic device if conservative options are unable to relieve pain and debilitating symptoms. THA was traditionally performed on patients over 60 years old, but now includes young and active patients, as well as very old ones thanks to the continuous improvement in implant design. Major indications of THA include osteoarthritis, rheumatoid arthritis, avascular necrosis and hip fractures. The THA surgical procedure involves replacing the head of the femur and acetabulum or socket with an artificial prosthesis. This system is composed of a femoral stem that is inserted into the femoral canal, a ball that attaches to the femoral stem, and an acetabular component or shell that replaces the acetabulum.

Trial Locations (6)

6900

Hôpital Princesse Paola, Aye

30900

Clinique Basseres Kacem-Boudhar, Nîmes

74130

CH Alpes Léman, Contamine-sur-Arve

74203

Hôpitaux Du Léman, Thonon-les-Bains

74370

CH Annecy Genevois, Épagny

83406

Hopital Renee Sabran, Hyères

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Zimmer Biomet

INDUSTRY

NCT04349046 - Exception Cementless Hip Stem | Biotech Hunter | Biotech Hunter